Fintech▲ 70

Hoth Therapeutics reports positive trial results

Prnewswire·April 1, 2026 at 12:14 PM

Hoth Therapeutics, Inc. has announced positive clinical results from an interim analysis of its ongoing trial for HT-001. The trial met its primary endpoint, with patients achieving an ARIGA score of ≤1 by week six. This encouraging outcome in Hungary suggests promising therapeutic potential and warrants further development.

Tickers

$HOTH

Hoth Therapeutics reports positive trial results

Companies Balance AI Opportunities With Fear of Bubble

Sona Secures $45 Million for AI Platform Expansion

Tariffs Reshape Business Strategy One Year Later

eToro launches crypto trading in New York